Pre-clinical translational medical product assessment
Total Trials
1
As Lead Sponsor
0
As Collaborator
Total Enrollment
90
NCT07204639
Safety and Efficacy of RAP-103 to Improve Severity and Quality of Life on Moderate to Severe Psoriasis in Subjects
Phase: Phase 2
Role: Collaborator
Start: Oct 1, 2025
Completion: Dec 30, 2025
Loading map...